Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

628 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HER2 Aberrations in NSCLC: So Close Yet So Far.
Sartori G, Belluomini L, Trovato R, Minari R, Caliò A, Ugel S, Milella M, Pilotto S. Sartori G, et al. Among authors: milella m. JCO Precis Oncol. 2020 Nov;4:1049-1051. doi: 10.1200/PO.20.00195. JCO Precis Oncol. 2020. PMID: 35050770 No abstract available.
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers.
Carbognin L, Pilotto S, Milella M, Vaccaro V, Brunelli M, Caliò A, Cuppone F, Sperduti I, Giannarelli D, Chilosi M, Bronte V, Scarpa A, Bria E, Tortora G. Carbognin L, et al. Among authors: milella m. PLoS One. 2015 Jun 18;10(6):e0130142. doi: 10.1371/journal.pone.0130142. eCollection 2015. PLoS One. 2015. PMID: 26086854 Free PMC article.
mTOR Cross-Talk in Cancer and Potential for Combination Therapy.
Conciatori F, Ciuffreda L, Bazzichetto C, Falcone I, Pilotto S, Bria E, Cognetti F, Milella M. Conciatori F, et al. Among authors: milella m. Cancers (Basel). 2018 Jan 19;10(1):23. doi: 10.3390/cancers10010023. Cancers (Basel). 2018. PMID: 29351204 Free PMC article. Review.
Do immune checkpoint inhibitors need new studies methodology?
Ferrara R, Pilotto S, Caccese M, Grizzi G, Sperduti I, Giannarelli D, Milella M, Besse B, Tortora G, Bria E. Ferrara R, et al. Among authors: milella m. J Thorac Dis. 2018 May;10(Suppl 13):S1564-S1580. doi: 10.21037/jtd.2018.01.131. J Thorac Dis. 2018. PMID: 29951307 Free PMC article. Review.
Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex.
Gkountakos A, Pilotto S, Mafficini A, Vicentini C, Simbolo M, Milella M, Tortora G, Scarpa A, Bria E, Corbo V. Gkountakos A, et al. Among authors: milella m. Carcinogenesis. 2018 Jul 30;39(8):971-980. doi: 10.1093/carcin/bgy086. Carcinogenesis. 2018. PMID: 29955840 Review.
Role of mTOR Signaling in Tumor Microenvironment: An Overview.
Conciatori F, Bazzichetto C, Falcone I, Pilotto S, Bria E, Cognetti F, Milella M, Ciuffreda L. Conciatori F, et al. Among authors: milella m. Int J Mol Sci. 2018 Aug 19;19(8):2453. doi: 10.3390/ijms19082453. Int J Mol Sci. 2018. PMID: 30126252 Free PMC article. Review.
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: a systematic review and meta-analysis.
Rossi A, Noia VD, Gkountakos A, D'Argento E, Sartori G, Vita E, Monteverdi S, Lombardo F, Iacovelli R, Carbognin L, Sperduti I, Milella M, Tortora G, Bria E, Pilotto S. Rossi A, et al. Among authors: milella m. Immunotherapy. 2019 Jul;11(10):921-930. doi: 10.2217/imt-2018-0198. Epub 2019 Jun 3. Immunotherapy. 2019. PMID: 31155995
628 results